Human Genome Sciences Inc. (HGS), a pioneering biotechnology firm headquartered in the United States, has been at the forefront of genomic research since its establishment in 1992. With a strong focus on developing innovative therapies for serious diseases, HGS operates primarily in the fields of genomics and biopharmaceuticals. The company is renowned for its unique approach to drug discovery, leveraging genomic data to create targeted treatments. Notable products include Benlysta, a groundbreaking therapy for lupus, which has solidified HGS's position in the biopharmaceutical market. Over the years, HGS has achieved significant milestones, including strategic partnerships and advancements in personalised medicine, further enhancing its reputation as a leader in the industry.
We don't have data for Human Genome Sciences Inc., but we can show you information about their parent organization instead.
View parent company